Genezen

Genezen and the Raiden Science Foundation Announce Partnership for AAV9 Gene Replacement Therapy for UBA5 Clinical Trial

Genezen and the Raiden Science Foundation (RSF), a parent-led rare disease organization, today announced a manufacturing partnership for an AAV Serotype 9 gene replacement therapy for UBA5 disorder.

Genezen Expands Partnership with SGS to Strengthen Support for Foundation-Funded Gene Therapy Programs

Expanded collaboration helps remove barriers and enables more programs to advance toward the clinic by improving and accelerating access to critical analytical and GMP biosafety testing.

Genezen and The Charlotte & Gwenyth Gray Foundation to Cure Batten Disease Announce Manufacturing Partnership for CLN6 Gene Therapy Clinical Trial

Genezen, a gene therapy contract development and manufacturing organization (CDMO), and The Charlotte & Gwenyth Gray Foundation to Cure Batten Disease today announced a manufacturing partnership to advance a CLN6 gene therapy into a Phase 1/2 clinical trial.

Genezen and Atsena Therapeutics Announce Strategic Commercial Manufacturing Partnership

Genezen, a leading gene therapy contract development and manufacturing organization (CDMO), and Atsena Therapeutics (“Atsena”), a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced a strategic…

Genezen Announces Manufacturing Partnership with Humane Genomics to Advance Oncolytic Virus Therapy for Pediatric Liver Cancer

Genezen, a leading gene therapy CDMO, has partnered with Elly’s Team, a foundation dedicated to accelerating the translation of medical research into treatments, for an AAV9 gene replacement therapy targeting Neurodevelopmental Disorder with Regression, Abnormal Movements, Loss of Speech, and…

Genezen Partners with Charlotte & Gwenyth Gray Foundation on CLN6 Batten Disease

Imagine a disease that robs you of your sight, your movement, and cognitively impairs you before it becomes fatal? Now imagine this happening to a child. This is often the reality of Batten's disease.